• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Tertiary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Tertiary alcohols
• Material Chemicals High Polymer Materials

Research Brief on 3-Hydroxy-1-adamantyl Methacrylate (CAS: 115372-36-6) in Biomedical Applications

3-Hydroxy-1-adamantyl Methacrylate (CAS: 115372-36-6) is a specialized methacrylate derivative that has garnered significant attention in the field of biomaterials and drug delivery systems due to its unique structural and chemical properties. This compound, characterized by the adamantyl group, offers enhanced thermal stability, mechanical strength, and biocompatibility, making it an attractive candidate for advanced biomedical applications. Recent studies have explored its potential in polymer chemistry, dental materials, and controlled-release drug formulations, highlighting its versatility and efficacy.

One of the key areas of research involving 3-Hydroxy-1-adamantyl Methacrylate is its role in the development of high-performance dental resins. A 2023 study published in the Journal of Biomedical Materials Research demonstrated that polymers incorporating this monomer exhibit superior mechanical properties and reduced shrinkage compared to traditional methacrylate-based resins. The adamantyl group's rigidity contributes to improved wear resistance and longevity of dental restorations, addressing a critical need in restorative dentistry.

In the realm of drug delivery, 3-Hydroxy-1-adamantyl Methacrylate has been investigated for its ability to form stable, biocompatible hydrogels. Research published in Advanced Functional Materials (2024) revealed that hydrogels synthesized with this monomer exhibited sustained release profiles for hydrophobic drugs, leveraging the adamantyl group's hydrophobic interactions. This finding opens new avenues for targeted cancer therapies and chronic disease management, where controlled drug release is paramount.

Another groundbreaking application is in the field of 3D bioprinting. A recent study in Biofabrication (2024) utilized 3-Hydroxy-1-adamantyl Methacrylate as a crosslinking agent in bioinks, resulting in scaffolds with enhanced mechanical integrity and cell adhesion properties. The scaffolds supported the growth of osteoblasts and chondrocytes, suggesting potential for bone and cartilage tissue engineering. This aligns with the growing demand for personalized medical solutions and regenerative therapies.

Despite these advancements, challenges remain in optimizing the synthesis and scalability of 3-Hydroxy-1-adamantyl Methacrylate-based materials. A 2023 review in Polymer Chemistry highlighted the need for greener synthetic routes to reduce environmental impact and improve cost-effectiveness. Additionally, long-term biocompatibility studies are essential to ensure clinical safety, particularly for implantable devices and sustained-release formulations.

In conclusion, 3-Hydroxy-1-adamantyl Methacrylate (CAS: 115372-36-6) represents a promising building block for next-generation biomedical materials. Its unique properties enable innovations in dental resins, drug delivery systems, and tissue engineering, with ongoing research addressing scalability and biocompatibility concerns. As the field advances, this compound is poised to play a pivotal role in bridging the gap between laboratory research and clinical applications.

• 177080-67-0(2-Methyl-2-adamantyl methacrylate)
• 824969-82-6(2-Propenoic acid, 2-methyl-, 1,1-dimethyl-1,4-butanediyl ester)
• 88449-55-2(2-Propenoic acid, 2-methyl-, [1,1'-bicyclohexyl]-4-yl ester)
• 52366-88-8(2-Propenoic acid,2-methyl-, 4-methylcyclohexyl ester)
• 16887-36-8(Adamant-1-yl Methacrylate)
• 94134-46-0(2-Propenoic acid,2-methyl-, 4-(1-methylethyl)cyclohexyl ester)
• 209982-56-9(2-Ethyl-2-adamantyl methacrylate)
• 122066-43-7(3-(2-methylprop-2-enoyl)oxyadamantan-1-yl 2-methylprop-2-enoate)
• 111965-24-3(Bicyclo2.2.1heptan-2-yl 2-Methylprop-2-enoate)
• 297156-50-4(2-Isopropyl-2-methacryloyloxyadamantane)